Kobe, Japan

Minoru Otsuka

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minoru Otsuka. Retrieved from https://idiyas.com/inventor/minoru-otsuka-nazl0vup

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Minoru Otsuka: Innovator in Cardiac Health

Introduction

Minoru Otsuka is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of cardiac health through his innovative research and development.

Latest Patents

Otsuka holds a patent for a venous extensibility improving and cardiac hypertrophy suppressant agent. This patent, which involves dihydropyridine compounds, is designed to enhance venous extensibility and suppress cardiac hypertrophy. The specific formula includes a nitrophenyl group and lower alkyl groups or pharmaceutically acceptable salts.

Career Highlights

Minoru Otsuka is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research. His work focuses on developing effective treatments for cardiovascular conditions.

Collaborations

Otsuka has collaborated with Takaharu Ono, contributing to the advancement of their shared research interests in cardiac health.

Conclusion

Minoru Otsuka's innovative work in cardiac health exemplifies the impact of dedicated research in improving medical treatments. His contributions continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…